Cargando…

Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits

Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due to their rapid action and broad spectrum of microbicidal activity, offering protection against bacteria a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Alaa M., Hill, Harriet J., Elkhouly, Gehad E., Bakkar, Marwa Reda, Raya, Nermeen R., Stamataki, Zania, Abo-zeid, Yasmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686650/
https://www.ncbi.nlm.nih.gov/pubmed/36358211
http://dx.doi.org/10.3390/antibiotics11111556
_version_ 1784835805862166528
author Ali, Alaa M.
Hill, Harriet J.
Elkhouly, Gehad E.
Bakkar, Marwa Reda
Raya, Nermeen R.
Stamataki, Zania
Abo-zeid, Yasmin
author_facet Ali, Alaa M.
Hill, Harriet J.
Elkhouly, Gehad E.
Bakkar, Marwa Reda
Raya, Nermeen R.
Stamataki, Zania
Abo-zeid, Yasmin
author_sort Ali, Alaa M.
collection PubMed
description Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due to their rapid action and broad spectrum of microbicidal activity, offering protection against bacteria and viruses. However, their frequent administration during COVID-19 pandemic was associated with serious hazards, such as skin toxicity, including irritation, skin dermatitis, skin dryness or cracking, along with peeling redness or itching, with the higher possibility of getting infections. Thus, there is a need to find alternative and novel approaches for hand sanitation. In our previous publications, we reported that rhamnolipids nano-micelles had a comparable antibacterial activity to alcohol-based hand sanitizer and a lower cytotoxicity against human dermal fibroblast cells. In the current study, we investigated the antiviral activity of rhamnolipids nano-micelles against SARS-CoV-2. There was no cytotoxic effect on Vero cells noted at the tested concentrations of rhamnolipids nano-micelles. The rhamnolipids nano-micelles solution at 20, 78, and 312 µg/mL all demonstrated a significant (p < 0.05) decrease of virus infectivity compared to the virus only and the blank vehicle sample. In addition, an acute irritation test was performed on rabbits to further ascertain the biosafety of rhamnolipids nano-micelles. In the eye and skin irritation tests, no degree of irritation was recorded after topical application of rhamnolipids nano-micelles. In addition, histopathological, biomarker, and hematological analyses from animals treated with rhamnolipids nano-micelles were identical to those recorded for untreated animal. From the above, we can conclude that rhamnolipids nano-micelles are a good candidate to be used as a hand sanitizer instead of alcohol-based hand sanitizers. However, they must still be tested in the future among healthcare workers (HCW) in a health care setting to ascertain their antimicrobial efficacy and safety compared to alcohol-based hand sanitizers.
format Online
Article
Text
id pubmed-9686650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96866502022-11-25 Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits Ali, Alaa M. Hill, Harriet J. Elkhouly, Gehad E. Bakkar, Marwa Reda Raya, Nermeen R. Stamataki, Zania Abo-zeid, Yasmin Antibiotics (Basel) Article Hand hygiene is considered to be the key factor in controlling and preventing infection, either in hospital care settings or in the community. Alcohol-based hand sanitizers are commonly used due to their rapid action and broad spectrum of microbicidal activity, offering protection against bacteria and viruses. However, their frequent administration during COVID-19 pandemic was associated with serious hazards, such as skin toxicity, including irritation, skin dermatitis, skin dryness or cracking, along with peeling redness or itching, with the higher possibility of getting infections. Thus, there is a need to find alternative and novel approaches for hand sanitation. In our previous publications, we reported that rhamnolipids nano-micelles had a comparable antibacterial activity to alcohol-based hand sanitizer and a lower cytotoxicity against human dermal fibroblast cells. In the current study, we investigated the antiviral activity of rhamnolipids nano-micelles against SARS-CoV-2. There was no cytotoxic effect on Vero cells noted at the tested concentrations of rhamnolipids nano-micelles. The rhamnolipids nano-micelles solution at 20, 78, and 312 µg/mL all demonstrated a significant (p < 0.05) decrease of virus infectivity compared to the virus only and the blank vehicle sample. In addition, an acute irritation test was performed on rabbits to further ascertain the biosafety of rhamnolipids nano-micelles. In the eye and skin irritation tests, no degree of irritation was recorded after topical application of rhamnolipids nano-micelles. In addition, histopathological, biomarker, and hematological analyses from animals treated with rhamnolipids nano-micelles were identical to those recorded for untreated animal. From the above, we can conclude that rhamnolipids nano-micelles are a good candidate to be used as a hand sanitizer instead of alcohol-based hand sanitizers. However, they must still be tested in the future among healthcare workers (HCW) in a health care setting to ascertain their antimicrobial efficacy and safety compared to alcohol-based hand sanitizers. MDPI 2022-11-04 /pmc/articles/PMC9686650/ /pubmed/36358211 http://dx.doi.org/10.3390/antibiotics11111556 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ali, Alaa M.
Hill, Harriet J.
Elkhouly, Gehad E.
Bakkar, Marwa Reda
Raya, Nermeen R.
Stamataki, Zania
Abo-zeid, Yasmin
Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
title Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
title_full Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
title_fullStr Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
title_full_unstemmed Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
title_short Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits
title_sort rhamnolipid nano-micelles inhibit sars-cov-2 infection and have no dermal or eye toxic effects in rabbits
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686650/
https://www.ncbi.nlm.nih.gov/pubmed/36358211
http://dx.doi.org/10.3390/antibiotics11111556
work_keys_str_mv AT alialaam rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits
AT hillharrietj rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits
AT elkhoulygehade rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits
AT bakkarmarwareda rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits
AT rayanermeenr rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits
AT stamatakizania rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits
AT abozeidyasmin rhamnolipidnanomicellesinhibitsarscov2infectionandhavenodermaloreyetoxiceffectsinrabbits